Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

the lawmakers said insulin was a "critical public health need" and they reminded them that patients with Type 1 diabetes need steady access to short-acting insulin. Which insulin brands are in ...

It’s given at the start of a meal and can act as an insulin replacement for some patients or a supplement for others who need slow-acting insulin. Dr. Kannan said it’s historically been ...

November is National Diabetes month, and it’s a great time to raise awareness about diabetes and to learn how to prevent or delay Type 2 diabetes, especially if it runs in your family. Well, let me ...

“It doesn’t ever stop.” People with type 1 and some with type 2 can face multiple daily injections of insulin. Short-acting insulin covers the spike in glucose that comes with meal ...

Summary: Insulin detemir is a long-acting, neutral, and soluble insulin analogue with a lower within-subject variability of fasting plasma glucose levels than isophane insulin human (NPH insulin ...

insulin conjugates with properties such as NNC2215 hold promise for improving treatment of diabetes by potentially lowering the risk of hypoglycemia and partly covering the need for fast-acting ...

Lawmakers have underscored the importance of steady access to short-acting insulin, which is essential for patients with Type 1 diabetes. Several factors have contributed to the shortages.

Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to Humalog, a rapid-acting insulin that is Lilly’s top selling drug, bringing in almost $700 ...